← Leaderboards
Justin R Fallon
Brown University
$12,690,507
Attributed
$13,139,234
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.9M · FY2005–23$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$22,769,414 · 13
By mechanism
U01$10,657,020 · 2
P01$4,956,135 · 2
R01$3,086,794 · 2
P20$1,560,830 · 2
R21$1,257,420 · 3
T32$854,301 · 1
Top collaborators
- Thomas Serre1 shared
- Ashley E Webb1 shared
Most similar at Brown University
Same institution · by research overlap
- Joel D Richter$33,526,627
- Thomas Serre$3,279,539
Others in their field
Top investigators on “Laboratory Mouse”
- Richard K. Wilson · Washington University$122,948,010
- Frank Patrick McCormick · University Of California San Francisco$87,382,096
- David Heimbrook · Leidos Biomedical Research, Inc.$81,904,667
- Kc Kent Lloyd · University Of California At Davis$56,148,943
- Alfred G Gilman · University Of Texas Sw Med Ctr/Dallas$53,869,943
- Carol J Bult · Jackson Laboratory$47,860,052
Research focus
Laboratory MouseMuscle CellsProtein BiosynthesisAgrinProteinsBoysDoseCell LineSarcolemmaLaboratoriesGene TargetingStagingBiochemicalProtein LocalizationNeural PlasticityMouse ModelPolyadenylateDevelopmental NeurobiologyRna Binding ProteinAlzheimer&AposMuscular Dystrophy, DuchenneDystrophinGeneticMuscle
Grant awards (43)
Promoting adult hippocampal neurogenesis in Alzheimer's Disease using an antibody-based therapy$396,914
R41 · FY2023 · AG · contact PI
Promoting adult hippocampal neurogenesis in Alzheimer's Disease Models$450,579
R21 · FY2021 · AG · contact PI
Next generation machine vision for automated behavioral phenotyping of knock-in ALS-FTD mouse models$446,875
R21 · FY2020 · NS · contact PI
Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy$1,336,500
U01 · FY2014 · NS · contact PI
"Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy"$1,336,500
U01 · FY2014 · NS · contact PI
"Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy"$1,336,500
U01 · FY2011 · NS · contact PI
Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy$1,336,500
U01 · FY2011 · NS · contact PI
"Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy"$1,323,135
U01 · FY2010 · NS · contact PI
Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy$1,323,135
U01 · FY2010 · NS · contact PI
Experience-dependent regulation of the Fragile X gene$255,627
R01 · FY2010 · HD · contact PI
"Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy"$1,332,375
U01 · FY2009 · NS · contact PI
Development of biglycan as a therapeutic for Duchenne Muscular Dystrophy$1,332,375
U01 · FY2009 · NS · contact PI
Experience-dependent regulation of the Fragile X gene$258,462
R01 · FY2009 · HD · contact PI
Experience-dependent regulation of the Fragile X gene$258,705
R01 · FY2008 · HD · contact PI
Testing a Novel DMD Therapeutic in MDX Mice$127,267
R21 · FY2008 · AR · contact PI
Experience-dependent regulation of the Fragile X gene$263,823
R01 · FY2007 · HD · contact PI
Testing a Novel DMD Therapeutic in MDX Mice$232,699
R21 · FY2007 · AR · contact PI
Experience-dependent regulation of the Fragile X gene$269,300
R01 · FY2006 · HD · contact PI
NERVE-MUSCLE SYNAPSE ORGANIZING MOLECULES$350,119
R01 · FY2005 · HD
GENETIC MODELS OF HUMAN DEMENTIAS$168,166
P20 · FY2005 · RR
CONTROL OF PROTEIN SYNTHESIS-DEPENDENT SYNAPTIC PLASTIC$906,700
P01 · FY2004 · NS
NERVE-MUSCLE SYNAPSE ORGANIZING MOLECULES$386,343
R01 · FY2004 · HD
GENETIC MODELS OF HUMAN DEMENTIAS$209,884
P20 · FY2004 · RR
CONTROL OF PROTEIN SYNTHESIS-DEPENDENT SYNAPTIC PLASTIC$873,780
P01 · FY2003 · NS
NERVE-MUSCLE SYNAPSE ORGANIZING MOLECULES$386,454
R01 · FY2003 · HD
INTERDISCIPLINARY PREDOCTORAL NEUROSCIENCE TRAINING$227,273
T32 · FY2003 · MH
NERVE-MUSCLE SYNAPSE ORGANIZING MOLECULES$6,018
R01 · FY2003 · HD
CONTROL OF PROTEIN SYNTHESIS-DEPENDENT SYNAPTIC PLASTIC$855,737
P01 · FY2002 · NS
NERVE-MUSCLE SYNAPSE ORGANIZING MOLECULES$314,342
R01 · FY2002 · HD
Genetics models of human dementias$236,556
P20 · FY2002 · RR
Genetics models of human dementias$236,556
P20 · FY2002 · RR
INTERDISCIPLINARY PREDOCTORAL NEUROSCIENCE TRAINING$220,048
T32 · FY2002 · MH
Polyadenylation in dendritic targeting of mRNA$218,155
P01 · FY2002 · NS
CONTROL OF PROTEIN SYNTHESIS-DEPENDENT SYNAPTIC PLASTIC$826,001
P01 · FY2001 · NS
NERVE-MUSCLE SYNAPSE ORGANIZING MOLECULES$337,601
R01 · FY2001 · HD
Genetics models of human dementias$236,556
P20 · FY2001 · RR
Genetics models of human dementias$236,556
P20 · FY2001 · RR
Polyadenylation in dendritic targeting of mRNA$218,155
P01 · FY2001 · NS
INTERDISCIPLINARY PREDOCTORAL NEUROSCIENCE TRAINING$210,337
T32 · FY2001 · MH
CONTROL OF PROTEIN SYNTHESIS-DEPENDENT SYNAPTIC PLASTIC$839,452
P01 · FY2000 · NS
Genetics models of human dementias$236,556
P20 · FY2000 · RR
Polyadenylation in dendritic targeting of mRNA$218,155
P01 · FY2000 · NS
INTERDISCIPLINARY PREDOCTORAL NEUROSCIENCE TRAINING$196,643
T32 · FY2000 · MH